Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124875033 | 12487503 | 3 | F | 20160713 | 20160622 | 20160726 | EXP | US-AUROBINDO-AUR-APL-2016-08072 | AUROBINDO | 17.00 | YR | F | Y | 0.00000 | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124875033 | 12487503 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | U | 77031 | |||||||||
| 124875033 | 12487503 | 2 | C | CANNABIS | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124875033 | 12487503 | 1 | Product used for unknown indication |
| 124875033 | 12487503 | 2 | Substance use |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124875033 | 12487503 | HO |
| 124875033 | 12487503 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124875033 | 12487503 | Electrocardiogram QRS complex prolonged | |
| 124875033 | 12487503 | Generalised tonic-clonic seizure | |
| 124875033 | 12487503 | Hypotension | |
| 124875033 | 12487503 | Overdose | |
| 124875033 | 12487503 | Syncope | |
| 124875033 | 12487503 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |